Author/Editor     Takač, I; Arko, D; Bali, R; Bosilj, D; Čas-Sikošek, N; Ognjenovik, D; Gorišek, B; Kodrič, T; Zukanović, D
Title     Diagnostični pomen testa HPV po zdravljenju CIN in izsledki slovenskih raziskav
Translated title     Diagnostic value of HPV testing after CIN treatment: Slovene research data
Type     članek
Source     In: Možina A, editor. HPV in preprečevanje raka materičnega vratu: kje smo in kako naprej?: mednarodni znanstveni simpozij; 2005 okt 7; Ljubljana. Ljubljana: Združenje za ginekološko onkologijo, kolposkopijo in cervikalno patologijo,
Publication year     2005
Volume     str. 43-56
Language     slo
Abstract     Background. Human papilloma virus (HPV) is usually eradicated after treatment of cervical intraepithelial neoplasia (CIN) indicating causal therapy. The negative predictive value of a negative HPV test is very high since a negative HPV test almost eacludes CIN persistence or recurrence. This is also true after incomplete resection of CIN. Sensitivity of a HPV test with regard to detection of CIN recurrence is high. Methods. On the basis of prospective collected data from 38 patients with CIN, in which reconization was performed at the Department of Gynecologic and Breast Oncology of Maribor Teaching Hospital in the period from 1.1.1999 to 31.12.2004, their infection with high risk HPV types was analyzed. Results. In the observation period reconization was performed in 6.5% of patients. Before reconization, 21 patients (55.3%) were infected with high-risk HPV and 17 patients (44.7%) were HPV negative. Among HPV negative patients, two (11.8%) had CIN 1, five (29.4%) CIN 2, nine (52.9%) CIN 3 and one patient (5.9%) had microinvasive cancer of the uterine cervix. Conclusions. On the basis of study results we cannot recommended the HPV test as the only method of detection of residual or recurrent CIN after conization, The combination of cytology and HPV testing increases the safety of follow-up after CIN therapy. The conclusions, however, are preliminary because of missing prospective and controlled trials.
Descriptors     CERVICAL INTRAEPITHELIAL NEOPLASIA
PAPILLOMAVIRUS, HUMAN
CONIZATION
IN SITU HYBRIDIZATION
REOPERATION